Response to “Stevens-Johnson syndrome and toxic epidermal necrolysis associated with the use of immune checkpoint inhibitors: A disproportionality analysis using the FDA Adverse Event Reporting System database”.

HOME
>
論文・技術情報
>
Response to “Stevens-Johnson syndrome and toxic epidermal necrolysis associated with the use of immune checkpoint inhibitors: A disproportionality analysis using the FDA Adverse Event Reporting System database”.

アブストラクト
ジャーナル名	Journal of the American Academy of Dermatology
Pubmed追加日	2025/7/1
投稿者	Kolodney, Michael S; Kolodney, Joanna A
組織名	Department of Dermatology, West Virginia University, Morgantown, West Virginia.;Electronic address: michael.kolodney@hsc.wvu.edu.;Department of Medical Oncology, West Virginia University, Morgantown, West;Virginia.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/40588131/